SCHEMBL21397562

SCHEMBL21397562

c1ccc2nc(-c3cn4ccccc4n3)cnc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.58
RAB9A P51151 14/20 0.53
NPC1 O15118 13/20 0.53
SMN1; SMN2 Q16637 8/20 0.53
KDM4E B2RXH2 8/20 0.50
POLB P06746 2/20 0.50
GFER P55789 2/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
ALOX12 P18054 1/20 0.49
ALDH1A1 P00352 6/20 0.48
HPGD P15428 2/20 0.48
PKM P14618 5/20 0.47
MAPK1 P28482 2/20 0.47
EPHX2 P34913 1/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
MIF P14174 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31731985 0.82 RAB9A (0.67) RAB9ANPC1SMN1; SMN2KDM4EPOLB
SCHEMBL3076524 0.76 NPC1 (0.63) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL29614829 0.76 NPC1 (0.63) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL29942654 0.76 NPC1 (0.63) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL29966674 0.76 NPC1 (0.63) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL10515978 0.75 RAB9A (0.54) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL30944801 0.75 RAB9A (0.54) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL15033460 0.74 PDE10A (0.55) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL7457993 0.74 PDE10A (1.00) PDE10ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL13325909 0.73 RAB9A (0.83) RAB9ANPC1SMN1; SMN2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019183367-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed